Literature DB >> 10331130

Carbon monoxide poisoning.

L K Weaver1.   

Abstract

Carbon monoxide (CO) poisoning is common and frequently unrecognized since the signs and symptoms are relatively nonspecific. CO poisoning causes tissue hypoxia. Additionally, various animal studies have demonstrated that CO interferes with myoglobin, P450, and other enzyme function; causes lipid peroxidation through neutrophil activation; produces oxidative stress manifested by peroxynitrate deposition in endothelium; binds to cytochrome aa3, disrupting intracellular oxygen utilization; can cause neuroexcitotoxicity; and contributes to hippocampal cellular death through apoptosis. Emergency treatment for CO poisoning is 100% oxygen. Hyperbaric oxygen therapy (HBO2) is accepted in CO poisoning, although data from randomized clinical trials regarding the efficacy of HBO2 in CO poisoning is conflicting. CO poisoning, even when treated with supplemental oxygen can leave the patient with permanent neurocognitive or affective problems. Unfortunately, there appears to be no marker or constellation of signs or symptoms at presentation that predicts long-term outcome following CO poisoning. Given the neurocognitive sequelae following CO poisoning, increased awareness and prevention of CO poisoning is imperative.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331130     DOI: 10.1016/s0749-0704(05)70056-7

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  30 in total

Review 1.  Hyperbaric oxygen for carbon monoxide poisoning.

Authors:  Nick A Buckley; David N Juurlink; Geoff Isbister; Michael H Bennett; Eric J Lavonas
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

2.  Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials.

Authors:  Djillali Annane; Karim Chadda; Philippe Gajdos; Marie-Claude Jars-Guincestre; Sylvie Chevret; Jean-Claude Raphael
Journal:  Intensive Care Med       Date:  2010-12-02       Impact factor: 17.440

3.  The effect of smoking status on burn inhalation injury mortality.

Authors:  Laquanda Knowlin; Lindsay Stanford; Bruce Cairns; Anthony Charles
Journal:  Burns       Date:  2016-10-01       Impact factor: 2.744

Review 4.  Update on hyperbaric oxygen therapy in burn treatment.

Authors:  Laurenz Weitgasser; Gerald Ihra; Bruno Schäfer; Klaus Markstaller; Christine Radtke
Journal:  Wien Klin Wochenschr       Date:  2019-11-07       Impact factor: 1.704

Review 5.  Carbon Monoxide and Cyanide Poisoning in the Burned Pregnant Patient: An Indication for Hyperbaric Oxygen Therapy.

Authors:  Derek M Culnan; Beretta Craft-Coffman; Genevieve H Bitz; Karel D Capek; Yiji Tu; William C Lineaweaver; Maggie J Kuhlmann-Capek
Journal:  Ann Plast Surg       Date:  2018-03       Impact factor: 1.539

6.  Cerebrovascular ischaemia after carbon monoxide intoxication.

Authors:  Hasan Kara; A Bayir; Ahmet Ak; Selim Degirmenci
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

7.  Design, Synthesis, and Biological Evaluation of Allosteric Effectors That Enhance CO Release from Carboxyhemoglobin.

Authors:  Sara R Goldstein; Chen Liu; Martin K Safo; Akito Nakagawa; Warren M Zapol; Jeffrey D Winkler
Journal:  ACS Med Chem Lett       Date:  2018-05-11       Impact factor: 4.345

Review 8.  Identifying and managing adverse environmental health effects: 6. Carbon monoxide poisoning.

Authors:  Alan Abelsohn; Margaret D Sanborn; Barry J Jessiman; Erica Weir
Journal:  CMAJ       Date:  2002-06-25       Impact factor: 8.262

9.  Effect of hyperbaric oxygen therapy on whole blood cyanide concentrations in carbon monoxide intoxicated patients from fire accidents.

Authors:  Pia Lawson-Smith; Erik C Jansen; Linda Hilsted; Ole Hyldegaard
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2010-06-15       Impact factor: 2.953

Review 10.  [Dermal and inhalation poisoning. Rare guests in our intensive care units?].

Authors:  I Sagoschen
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-08-09       Impact factor: 0.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.